Regulation of synthetic cannabinoids

The Lancet

Volumn 374, Issue 9701, 2009, Pages 1595-

  Ashton, C Heather ^a   Moore, P Brian ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID DERIVATIVE; CANNABIS; TETRAHYDROCANNABINOL; ANTIEMETIC AGENT; DRUG DERIVATIVE; NABILONE;

CIGARETTE SMOKING; HEALTH CARE PERSONNEL; LABORATORY TEST; LETTER; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; PRIORITY JOURNAL; CANNABIS SMOKING; DRUG CONTROL; HUMAN; LEGAL ASPECT; METHODOLOGY; NOTE; ORGANIZATION AND MANAGEMENT; PHYTOTHERAPY; UNITED KINGDOM;

ANTIEMETICS; DRUG AND NARCOTIC CONTROL; GREAT BRITAIN; HUMANS; MARIJUANA SMOKING; PHYTOTHERAPY; TETRAHYDROCANNABINOL;

EID: 70350608449     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61949-8     Document Type: Letter

References (4)

1. McLachlan G. Taking the spice out of legal smoking mixtures. Lancet 374 (2009) 600
2. British Medical Association, Royal Pharmaceutical Society of Great Britain. British national formulary vol 57 (2009), BMJ Group, London
3. British Medical Association. Therapeutic uses of cannabis (1997), BMA, London
4. Ashton C.H. Therapeutic uses of cannabis-an update. Syva Drug Monitor 4 (2005) 50-52